Combination Therapy of Omalizumab and Allergen Immunotherapy for Moderate to Severe Asthma

Clinical trial NCT06771934 · UNKNOWN

Trial details

NCT number: NCT06771934
Sponsor: Qianfoshan Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Allergic Asthma

Start date: 2024-06-01
Primary completion: 2025-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.